{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:49:10Z","timestamp":1785786550849,"version":"3.56.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.cgh.2012.07.006","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T20:47:17Z","timestamp":1343076437000},"page":"1315-1325.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Strategies for the Care of Adults Hospitalized for Active Ulcerative Colitis"],"prefix":"10.1016","volume":"10","author":[{"given":"Suresh","family":"Pola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ramamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"McLemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Rivera\u2013Nieves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Docherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Talamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Sandborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2012.07.006_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/gut.4.4.299","article-title":"The course and prognosis of ulcerative colitis","volume":"4","author":"Edwards","year":"1963","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","article-title":"The pattern and outcome of acute severe colitis","volume":"4","author":"Dinesen","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2012.07.006_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.dld.2011.11.009","article-title":"Surgical and nonsurgical hospitalization rates and charges for patients with ulcerative colitis in Italy: a 10-year cohort study","volume":"44","author":"Kohn","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2006.09.033","article-title":"Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression","volume":"5","author":"Turner","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11605-010-1396-3","article-title":"A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations","volume":"15","author":"Ananthakrishnan","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.cgh.2012.07.006_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ajg.2011.386","article-title":"Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements","volume":"107","author":"Bitton","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM199603283341307","article-title":"Inflammatory bowel disease","volume":"334","author":"Hanauer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2012.07.006_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0140-6736(90)91521-B","article-title":"Preliminary report: cyclosporin in treatment of severe active ulcerative colitis","volume":"336","author":"Lichtiger","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2012.07.006_bib9","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2012.07.006_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2011.10.032","article-title":"Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis","volume":"142","author":"Sandborn","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/BF01295733","article-title":"Clinical patterns, natural history, and progression of ulcerative colitis","volume":"38","author":"Farmer","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2012.07.006_bib12","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/BF02088063","article-title":"Colonoscopy of acute colitis","volume":"39","author":"Carbonnel","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2012.07.006_bib13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-2036.2004.01945.x","article-title":"Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery","volume":"19","author":"Ho","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2012.07.006_bib14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(74)90552-2","article-title":"Intensive intravenous regimen for severe attacks of ulcerative colitis","volume":"1","author":"Truelove","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2012.07.006_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gut.38.6.905","article-title":"Predicting outcome in severe ulcerative colitis","volume":"38","author":"Travis","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_bib16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-2008-1077445","article-title":"Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease","volume":"40","author":"Terheggen","year":"2008","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2012.07.006_bib17","first-page":"187","article-title":"Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making","volume":"86","author":"Alemayehu","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.crohns.2010.12.005","article-title":"Prevalence and risk factors for colonic perforation during colonoscopy in hospitalized inflammatory bowel disease patients","volume":"5","author":"Navaneethan","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2012.07.006_bib19","article-title":"Therapeutic approaches to the treatment of ulcerative colitis","volume":"415","author":"Sandborn","year":"2010"},{"key":"10.1016\/j.cgh.2012.07.006_bib20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/0016-5085(95)90154-X","article-title":"Exacerbation of chronic ulcerative colitis with mesalamine","volume":"108","author":"Sturgeon","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/gut.37.6.838","article-title":"Mesalazine induced exacerbation of ulcerative colitis","volume":"37","author":"Kapur","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4292\/wjgpt.v1.i6.132","article-title":"Mesalamine induced symptom exacerbation of ulcerative colitis: case report and brief discussion","volume":"1","author":"Gupta","year":"2010","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.cgh.2012.07.006_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmj.2.5302.441","article-title":"Out-patient treatment of ulcerative colitis","volume":"2","author":"Baron","year":"1962","journal-title":"Br Med J"},{"key":"10.1016\/j.cgh.2012.07.006_bib24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/00365527809182199","article-title":"A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis","volume":"13","author":"Powell-Tuck","year":"1978","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004836-198702000-00013","article-title":"Predicting the outcome of corticoid therapy for acute ulcerative colitis","volume":"9","author":"Meyers","year":"1987","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib26","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0140-6736(78)91816-0","article-title":"Further experience in the treatment of severe attacks of ulcerative colitis","volume":"2","author":"Truelove","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2012.07.006_bib27","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0016-5085(85)90201-X","article-title":"Intensive intravenous treatment of ulcerative colitis","volume":"89","author":"J\u00e4rnerot","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib28","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1111\/j.1572-0241.2007.01435.x","article-title":"Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era","volume":"102","author":"Gustavsson","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.2010.320","article-title":"Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cgh.2012.07.006_bib30","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2012.07.006_bib31","first-page":"A714","article-title":"Long-term results of oral cyclosporin in patients with severe ulcerative colitis: a double-blind, randomized, multi-center trial","volume":"106","author":"Kornbluth","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib32","article-title":"Effectiveness of cyclosporine A (CsA) in the treatment of active refractory ulcerative colitis (UC)","volume":"1998:A1096","author":"Svanoni","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2001.23983","article-title":"Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis","volume":"120","author":"D'Haens","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib34","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S0016-5085(11)60453-8","article-title":"Cyclosporin versus infliximab in severe acute ulcerative colitis refractory to intravenous steroids: a randomized trial","volume":"140","author":"Laharie","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1345\/aph.1G374","article-title":"Cyclosporine for severe ulcerative colitis","volume":"40","author":"Pham","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2012.07.006_bib36","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.1999.01149.x","article-title":"Intravenous cyclosporin in ulcerative colitis: a five-year experience","volume":"94","author":"Cohen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00054725-200403000-00002","article-title":"Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis","volume":"10","author":"Arts","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00042737-200501000-00016","article-title":"Ciclosporin use in acute ulcerative colitis: a long-term experience","volume":"17","author":"Campbell","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_bib39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cgh.2006.04.001","article-title":"Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis","volume":"4","author":"Moskovitz","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-230X-7-13","article-title":"Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study","volume":"7","author":"Actis","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib41","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0016-5085(03)01214-9","article-title":"Randomized, double-blind comparison of 4 mg\/kg versus 2 mg\/kg intravenous cyclosporine in severe ulcerative colitis","volume":"125","author":"Van Assche","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00054725-200105000-00001","article-title":"Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study","volume":"7","author":"Sands","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib43","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1053\/j.gastro.2005.03.003","article-title":"Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study","volume":"128","author":"J\u00e4rnerot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib44","first-page":"231","article-title":"Infliximab in the treatment of steroid-dependent ulcerative colitis","volume":"8","author":"Armuzzi","year":"2004","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.cgh.2012.07.006_bib45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00042737-200411000-00014","article-title":"Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study","volume":"16","author":"Ochsenk\u00fchn","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_bib46","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/S0016-5085(11)60548-9","article-title":"Infliximab, azathioprine, or infliximab + azathioprine for treatment of moderate to severe ulcerative colitis: UC SUCCESS trial (abstract 835)","volume":"140","author":"Panaccione","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib47","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jamcollsurg.2006.12.044","article-title":"Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis","volume":"204","author":"Selvasekar","year":"2007","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.cgh.2012.07.006_bib48","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s10350-008-9364-7","article-title":"Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy","volume":"51","author":"Mor","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2012.07.006_bib49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2036.2009.04204.x","article-title":"Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis","volume":"31","author":"Yang","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2012.07.006_bib50","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s11605-008-0630-8","article-title":"Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications","volume":"12","author":"Kunitake","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.cgh.2012.07.006_bib51","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ibd.20863","article-title":"Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis","volume":"15","author":"Ferrante","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib52","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1007\/s00464-009-0861-0","article-title":"Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: a case-matched study","volume":"24","author":"Coquet-Reinier","year":"2010","journal-title":"Surg Endosc"},{"key":"10.1016\/j.cgh.2012.07.006_bib53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11605-010-1385-6","article-title":"Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis","volume":"15","author":"Gainsbury","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.cgh.2012.07.006_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.crohns.2011.08.014","article-title":"Infliximab and complications after colectomy in patients with ulcerative colitis","volume":"6","author":"Bregnbak","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2012.07.006_bib55","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cgh.2008.04.035","article-title":"Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis","volume":"6","author":"Maser","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_bib56","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ajg.2011.62","article-title":"Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis","volume":"106","author":"Leblanc","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib57","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1053\/j.gastro.2010.02.047","article-title":"Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response","volume":"138","author":"Turner","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib58","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00042737-199810000-00003","article-title":"Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis","volume":"10","author":"Lindgren","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ibd.20322","article-title":"Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine and validation in an independent cohort","volume":"14","author":"Aceituno","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib60","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/msj.20152","article-title":"Current surgical management of ulcerative colitis","volume":"76","author":"Grucela","year":"2009","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.cgh.2012.07.006_bib61","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s10350-005-0180-z","article-title":"Practice parameters for the surgical treatment of ulcerative colitis","volume":"48","author":"Cohen","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2012.07.006_bib62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/bmj.3.5559.193","article-title":"Early surgery in the management of severe ulcerative colitis","volume":"3","author":"Goligher","year":"1967","journal-title":"Br Med J"},{"key":"10.1016\/j.cgh.2012.07.006_bib63","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.4.5737.703","article-title":"Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation","volume":"4","author":"Goligher","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.cgh.2012.07.006_bib64","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/bmj.39345.714039.55","article-title":"Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies","volume":"335","author":"Roberts","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2012.07.006_bib65","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cgh.2011.07.016","article-title":"Postoperative complications and mortality following colectomy for ulcerative colitis","volume":"9","author":"de Silva","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_bib66","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/ibd.20500","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"14","author":"Issa","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib67","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","article-title":"A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.clinre.2011.02.004","article-title":"Clostridium difficile infection in patients with ulcerative colitis: investigations of risk factors and efficacy of antibiotics for steroid refractory patients","volume":"35","author":"Kaneko","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib69","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_bib70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cgh.2006.12.028","article-title":"Impact of Clostridium difficile on inflammatory bowel disease","volume":"5","author":"Issa","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_bib71","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cgh.2012.07.006_bib72","first-page":"A663","article-title":"Decreasing rates of colectomy despite high rates of hospitalization in Clostridium difficile infected IBD patients: a tertiary referral center experience","volume":"132","author":"Issa","year":"2007","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2012.07.006_bib73","first-page":"S1145","article-title":"Long-term impact of Clostridium difficile on inflammatory bowel disease","volume":"136","author":"Chiplunker","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib74","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2012.07.006_bib75","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1111\/j.1572-0241.2006.00869.x","article-title":"Cytomegalovirus colitis complicating inflammatory bowel disease","volume":"101","author":"Kandiel","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib76","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/ibd.21275","article-title":"Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?","volume":"16","author":"Lawlor","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib77","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.dld.2005.01.011","article-title":"Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection","volume":"37","author":"Maconi","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib78","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1572-0241.2001.03620.x","article-title":"Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis","volume":"96","author":"Cottone","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib79","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.dld.2004.05.013","article-title":"Severe acute colitis associated with CMV: a prevalence study","volume":"36","author":"Criscuoli","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib80","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ibd.20498","article-title":"Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy","volume":"14","author":"Dom\u00e8nech","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib81","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/BF01299914","article-title":"Cytomegalovirus infection associated with onset of inflammatory bowel disease","volume":"38","author":"Orvar","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2012.07.006_bib82","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.qco.0000136933.67920.dd","article-title":"Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients","volume":"17","author":"Pereyra","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib83","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ibd.20131","article-title":"Infliximab and the risk of latent viruses reactivation in active Crohn's disease","volume":"13","author":"Lavagna","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib84","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/jmv.21877","article-title":"Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases","volume":"82","author":"L\u00e9v\u00eaque","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.cgh.2012.07.006_bib85","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/ibd.20253","article-title":"Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies","volume":"13","author":"Yoshino","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib86","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, practice parameters committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib87","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"Rahier","year":"2009","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2012.07.006_bib88","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s11605-008-0661-1","article-title":"Fulminant colitis","volume":"12","author":"Sands","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.cgh.2012.07.006_bib89","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1572-0241.2003.07696.x","article-title":"A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management","volume":"98","author":"Gan","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib90","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0016-5085(19)33962-9","article-title":"An experience of ulcerative colitis","volume":"57","author":"Jalan","year":"1969","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib91","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1572-0241.2002.05691.x","article-title":"GI distension in severe ulcerative colitis","volume":"97","author":"Latella","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib92","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(97)10475-5","article-title":"Toxic megacolon","volume":"351","author":"Sheth","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2012.07.006_bib93","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0899-7071(01)00330-8","article-title":"Toxic megacolon: role of CT in evaluation and detection of complications","volume":"25","author":"Imbriaco","year":"2001","journal-title":"Clin Imaging"},{"key":"10.1016\/j.cgh.2012.07.006_bib94","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ibd.21847","article-title":"Toxic megacolon","volume":"18","author":"Autenrieth","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib95","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/gut.34.12.1726","article-title":"Toxic megacolon: the knee-elbow position relieves bowel distension","volume":"34","author":"Panos","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_bib96","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004836-198810000-00004","article-title":"Medical decompression of toxic megacolon by \u201crolling\u201d","volume":"10","author":"Present","year":"1988","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib97","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004836-197912000-00005","article-title":"Management of toxic megacolon: the significance of early recognition in medical management","volume":"1","author":"Katzka","year":"1979","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib98","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000088369","article-title":"Early surgery for the treatment of toxic megacolon","volume":"72","author":"D'Amico","year":"2005","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2012.07.006_bib99","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ibd.21806","article-title":"Narcotic use for inflammatory bowel disease and risk factors during hospitalization","volume":"18","author":"Long","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/DCR.0b013e3181e7562c","article-title":"Impact of narcotic use on the requirement for colectomy in inpatients with ulcerative colitis","volume":"53","author":"Lian","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2012.07.006_bib101","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_bib102","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0016-5085(80)90913-0","article-title":"Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis","volume":"79","author":"Dickinson","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_bib103","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/gut.27.5.481","article-title":"Controlled trial of bowel rest in the treatment of severe acute colitis","volume":"27","author":"McIntyre","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_bib104","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ibd.20429","article-title":"Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients","volume":"14","author":"Nguyen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib105","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ibd.21842","article-title":"Preoperative hypoalbuminemia is associated with adverse outcomes after ileoanal pouch surgery","volume":"18","author":"Nisar","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib106","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.MIB.0000160772.78951.61","article-title":"The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology","volume":"11","author":"Hatoum","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_bib107","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2012.07.006_bib108","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","article-title":"Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_bib109","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ajg.2011.53","article-title":"Venous thromboembolism in inflammatory bowel disease: an epidemiological review","volume":"106","author":"Murthy","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_fr1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0016-5085(83)90323-2","article-title":"Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis","volume":"85","author":"Meyers","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_fr2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3109\/00365527709181359","article-title":"A controlled comparison of corticotropin and hydrocortisone in the treatment of severe proctocolitis","volume":"12","author":"Powell-Tuck","year":"1977","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_fr3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2036.1990.tb00456.x","article-title":"The efficacy of tobramycin in the treatment of ulcerative colitis","volume":"4","author":"Burke","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2012.07.006_fr4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2036.1993.tb00084.x","article-title":"Oral tobramycin in ulcerative colitis: effect on maintenance of remission","volume":"7","author":"Lobo","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2012.07.006_fr5","first-page":"454","article-title":"A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis","volume":"92","author":"Mantzaris","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_fr6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0016-5085(98)70076-9","article-title":"Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study","volume":"115","author":"Turunen","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_fr7","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/gut.26.12.1380","article-title":"Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis","volume":"26","author":"Dickinson","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_fr8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gut.27.10.1210","article-title":"Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis","volume":"27","author":"Chapman","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_fr9","first-page":"43","article-title":"Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis","volume":"89","author":"Mantzaris","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_fr10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/003655201750305503","article-title":"A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis","volume":"36","author":"Mantzaris","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_fr11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/gut.2005.081794","article-title":"A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis","volume":"55","author":"Ogata","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_fr12","series-title":"Translating basic science into clinical practice","first-page":"415","article-title":"Therapeutic approaches to the treatment of ulcerative colitis","author":"Sandborn","year":"2010"},{"key":"10.1016\/j.cgh.2012.07.006_fr13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.crohns.2010.05.004","article-title":"Two cases of fatal Pneumocystis jirovecii pneumonia as a complication of tacrolimus therapy in ulcerative colitis\u2013a need for prophylaxis","volume":"4","author":"Escher","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2012.07.006_fr14","first-page":"S114","article-title":"Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis","volume":"138","author":"Reinisch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_fr15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2011.10.032","article-title":"Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis","volume":"142","author":"Sandborn","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_fr16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0016-5085(79)90386-X","article-title":"National cooperative Crohn's disease study: adverse reactions to study drugs","volume":"77","author":"Singleton","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_fr17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.cgh.2012.07.006_fr18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_fr19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"Toruner","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_fr20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.1994.00420010131015","article-title":"Glucocorticoids and the risk for initiation of hypoglycemic therapy","volume":"154","author":"Gurwitz","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2012.07.006_fr21","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJM199205283262206","article-title":"Nontraumatic necrosis of bone (osteonecrosis)","volume":"326","author":"Mankin","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2012.07.006_fr22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2036.2005.02231.x","article-title":"Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature","volume":"21","author":"Klingenstein","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2012.07.006_fr23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0889-857X(21)00353-7","article-title":"Glucocorticoid-induced osteoporosis","volume":"20","author":"Lukert","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.cgh.2012.07.006_fr24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF02597440","article-title":"Adverse neurologic effects of glucocorticosteroids","volume":"6","author":"Lacomis","year":"1991","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cgh.2012.07.006_fr25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0039-6257(86)90077-9","article-title":"Corticosteroid-induced cataracts","volume":"31","author":"Urban","year":"1986","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.cgh.2012.07.006_fr26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00004397-199303320-00013","article-title":"Corticosteroid-induced glaucoma","volume":"33","author":"Urban","year":"1993","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.cgh.2012.07.006_fr27","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1572-0241.2008.01836.x","article-title":"Immunosuppressant medications and mortality in inflammatory bowel disease","volume":"103","author":"Lewis","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_fr28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-111-8-641","article-title":"6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity","volume":"111","author":"Present","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2012.07.006_fr29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gut.34.8.1081","article-title":"Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience","volume":"34","author":"Connell","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_fr30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0016-5085(98)70251-3","article-title":"Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease","volume":"115","author":"Kirschner","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_fr31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.07.006_fr32","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2012.07.006_fr33","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.1999.01149.x","article-title":"Intravenous cyclosporin in ulcerative colitis: a five-year experience","volume":"94","author":"Cohen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_fr34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1572-0241.2007.01718.x","article-title":"Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease","volume":"103","author":"Sternthal","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_fr35","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cgh.2006.04.001","article-title":"Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis","volume":"4","author":"Moskovitz","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_fr36","first-page":"A1096","article-title":"Complications during cyclosporine therapy for inflammatory bowel disease","volume":"112","author":"Stein","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_fr37","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","article-title":"The incidence and management of infusion reactions to infliximab: a large center experience","volume":"98","author":"Cheifetz","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.07.006_fr38","series-title":"Prescribing information for Remicade (infliximab)","year":"2011"},{"key":"10.1016\/j.cgh.2012.07.006_fr39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2010.09.016","article-title":"A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease","volume":"9","author":"Kotlyar","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_fr40","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2012.07.006_fr41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.07.006_fr42","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.cgh.2009.07.019","article-title":"Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations","volume":"7","author":"Lewis","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.07.006_fr43","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2012.07.006_fr44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ibd.20261","article-title":"Prophylaxis against pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care","volume":"14","author":"Poppers","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.07.006_fr45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0140-6736(90)91521-B","article-title":"Preliminary report: cyclosporin in treatment of severe active ulcerative colitis","volume":"336","author":"Lichtiger","year":"1990","journal-title":"Lancet"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356512008324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356512008324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:11:15Z","timestamp":1761541875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356512008324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":154,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1542356512008324"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2012.07.006","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for the Care of Adults Hospitalized for Active Ulcerative Colitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2012.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}